Recognition in Enterprise Fintech underscores Osome's leadership in AI-enabled, expert-backed business management solutions – Osome, an AI-enabled business management platform, has been recognised in the Enterprise Fintech category of the inaugural Singapore's Top Fintech Companies 2026, an honours list of companies committed to excellence, innovation, and overall impact in the Fintech industry. https://mma.prnewswire.com/media/2814158/Tamas_Gogge.jpg The Singapore's […]

Onassis Holding Corp(OTC: ONSS) a US public company pioneering cellular rejuvenation and longevity biotechnology, is pleased to announce the appointment of Esq. Paz Itzhaki-Weinberger to its Advisory Board. Paz will lead the company's strategy on international law, trade, and cross border corporate affairs. https://mma.prnewswire.com/media/1708529/Onassis_Holdings_Corp_Logo.jpg PazItzhaki-Weinberger combines deep experience in technology, law, and international business. He

At Hong Kong FinTech Week 2025, Asia's premier financial technology event,LianLian Global, the cross-border payment brand of Hong Kong-listedLianlian DigiTech, announced a strategic partnership withPAYS0, a licensed payment company in the Philippines. The two companies are collaborating to provideOverseas Filipino Workers (OFWs)with an innovative cross-border remittance experience. The partnership was formalized with a signing ceremony

The PRIME product series features the world's only technology capable of regenerating lead-acid batteries without internal overheating. With regular maintenance and the use of a regenerator, lead-acid batteries can achieve up to 3 times the lifespan of typical use. Amid growing global concerns over lithium-ion battery fires, often referred to as “lithium fire phobia”, South

FUTURE (Future Holdings AG), Switzerland's premier Bitcoin Treasury Company, today announced the successful closing of its CHF 28 million strategic funding round. The round was anchored by cornerstone investors Fulgur Ventures, Nakamoto, and TOBAM, representing some of the most established names bridging traditional finance and Bitcoin. https://mma.prnewswire.com/media/2813272/Future_Holdings_Logo.jpg The company is spearheaded by a seasoned team

CelLBxHealth presents proof-of-concept study using Roche Tissue Diagnostics’ workflow at world-leading drug development conference Parsortix platform shown to be compatible with the Roche BenchMark ULTRA automated staining system, with initial study of three key drug targets: HER2 (breast), TROP2 (lung) and PSMA (prostate) GUILFORD, SURREY AND PLYMOUTH MEETING, PA / ACCESS Newswire / November 5,

MALMÖ, SE / ACCESS Newswire / November 5, 2025 / Ascelia Pharma (STO:ACE) – Ascelia Pharma AB (publ) (ticker:ACE) today published its Interim Report Q3 for 2025 (January – September), which is now available on the company’s website: Financial Reports – ASCELIA KEY EVENTS IN Q3 2025 New Drug Application (NDA) for Orviglance® submitted to

(NYSE MKT:CMCL),(LSE – AIM:CMCL),(LSE:CMCL.L),(LSE:CMCL.LN), ST HELIER, Jersey, Nov. 05, 2025 (GLOBE NEWSWIRE) — (NYSE AMERICAN, AIM and VFEX: CMCL) – Caledonia Mining Corporation Plc (“Caledonia” or “the Company”) is pleased to announce the appointment of Mr July Ndlovu to the board of directors of the Company (“the Board”) as an independent non-executive director. July Ndlovu

(Euronext Amsterdam:WKL),(Pinksheets:WTKWY),(PinkSheets:WTKWY), Wolters Kluwer 2025 Nine-Month Trading Update Alphen aan den Rijn, November 5, 2025 – Wolters Kluwer, a global leader in professional information solutions, software and services, today releases its scheduled 2025 nine-month trading update. Highlights Full-year 2025 guidance reaffirmed. Nine-month revenues up 7% in constant currencies and up 6% organically. Recurring revenues (84%

The MHRA (Medicines and Healthcare products Regulatory Agency) granted UK Marketing Authorisation for XOANACYL via the International Recognition Procedure (Route B) recognising its prior EU approval (June 2025) XOANACYL is an oral therapy designed to address two major unmet needs in CKD – Iron deficiency and elevated serum phosphorus – in a single drug AVEROA